Effect of the antiprogestin RU486 on human ovarian steroidogenesis

M. DiMattina, B. D. Albertson, V. Tyson, Donald (Lynn) Loriaux, R. J. Falk

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Previous studies in the authors' laboratory suggest that the antiprogestin RU486 may directly affect human ovarian progesterone production. The possibility that this compound could affect other steps in human ovarian steroidogenesis was examined by studying its effects on estrogen production in cultured human granulosa cells and on human ovarian aromatase (AR) and 17-hydroxylase (17-OH) activities in vitro. RU486 had no effect on media estradiol (E2) levels as measured by radioimmunoassay (RIA) over a 24-hour incubation period. Furthermore, no effect on ovarian AR activity occurred at concentrations of RU486 100 times substrate. However, a dose-dependent decrease in the activity of 17-OH was observed with increasing amounts of drug. RU486 decreased 17-OH activity by 12 and 29% below that of basal activity at concentrations equal to and ten times substrate. At 50- and 100-fold excess, RU486 further decreased 17-OH activity by 42 (P <0.01) and 48% (P <0.005). In conclusion, RU486 directly inhibits human ovarian 17-OH activity, but does not affect AR activity or E2 production in vitro. Clinically observed decreases in serum E2 levels may be due to inhibition of enzymatic steps proximal to E2 synthesis. These findings support the authors' previous observations suggesting that RU486 has a direct affect on human ovarian steroidogenesis.

Original languageEnglish (US)
Pages (from-to)229-233
Number of pages5
JournalFertility and Sterility
Volume48
Issue number2
StatePublished - 1987
Externally publishedYes

Fingerprint

Aromatase
Granulosa Cells
Mixed Function Oxygenases
Radioimmunoassay
Progesterone
Estradiol
Estrogens
Serum
Pharmaceutical Preparations
In Vitro Techniques

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

DiMattina, M., Albertson, B. D., Tyson, V., Loriaux, D. L., & Falk, R. J. (1987). Effect of the antiprogestin RU486 on human ovarian steroidogenesis. Fertility and Sterility, 48(2), 229-233.

Effect of the antiprogestin RU486 on human ovarian steroidogenesis. / DiMattina, M.; Albertson, B. D.; Tyson, V.; Loriaux, Donald (Lynn); Falk, R. J.

In: Fertility and Sterility, Vol. 48, No. 2, 1987, p. 229-233.

Research output: Contribution to journalArticle

DiMattina, M, Albertson, BD, Tyson, V, Loriaux, DL & Falk, RJ 1987, 'Effect of the antiprogestin RU486 on human ovarian steroidogenesis', Fertility and Sterility, vol. 48, no. 2, pp. 229-233.
DiMattina M, Albertson BD, Tyson V, Loriaux DL, Falk RJ. Effect of the antiprogestin RU486 on human ovarian steroidogenesis. Fertility and Sterility. 1987;48(2):229-233.
DiMattina, M. ; Albertson, B. D. ; Tyson, V. ; Loriaux, Donald (Lynn) ; Falk, R. J. / Effect of the antiprogestin RU486 on human ovarian steroidogenesis. In: Fertility and Sterility. 1987 ; Vol. 48, No. 2. pp. 229-233.
@article{a10a1da2a74d4a18976724e6b6ef63b5,
title = "Effect of the antiprogestin RU486 on human ovarian steroidogenesis",
abstract = "Previous studies in the authors' laboratory suggest that the antiprogestin RU486 may directly affect human ovarian progesterone production. The possibility that this compound could affect other steps in human ovarian steroidogenesis was examined by studying its effects on estrogen production in cultured human granulosa cells and on human ovarian aromatase (AR) and 17-hydroxylase (17-OH) activities in vitro. RU486 had no effect on media estradiol (E2) levels as measured by radioimmunoassay (RIA) over a 24-hour incubation period. Furthermore, no effect on ovarian AR activity occurred at concentrations of RU486 100 times substrate. However, a dose-dependent decrease in the activity of 17-OH was observed with increasing amounts of drug. RU486 decreased 17-OH activity by 12 and 29{\%} below that of basal activity at concentrations equal to and ten times substrate. At 50- and 100-fold excess, RU486 further decreased 17-OH activity by 42 (P <0.01) and 48{\%} (P <0.005). In conclusion, RU486 directly inhibits human ovarian 17-OH activity, but does not affect AR activity or E2 production in vitro. Clinically observed decreases in serum E2 levels may be due to inhibition of enzymatic steps proximal to E2 synthesis. These findings support the authors' previous observations suggesting that RU486 has a direct affect on human ovarian steroidogenesis.",
author = "M. DiMattina and Albertson, {B. D.} and V. Tyson and Loriaux, {Donald (Lynn)} and Falk, {R. J.}",
year = "1987",
language = "English (US)",
volume = "48",
pages = "229--233",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Effect of the antiprogestin RU486 on human ovarian steroidogenesis

AU - DiMattina, M.

AU - Albertson, B. D.

AU - Tyson, V.

AU - Loriaux, Donald (Lynn)

AU - Falk, R. J.

PY - 1987

Y1 - 1987

N2 - Previous studies in the authors' laboratory suggest that the antiprogestin RU486 may directly affect human ovarian progesterone production. The possibility that this compound could affect other steps in human ovarian steroidogenesis was examined by studying its effects on estrogen production in cultured human granulosa cells and on human ovarian aromatase (AR) and 17-hydroxylase (17-OH) activities in vitro. RU486 had no effect on media estradiol (E2) levels as measured by radioimmunoassay (RIA) over a 24-hour incubation period. Furthermore, no effect on ovarian AR activity occurred at concentrations of RU486 100 times substrate. However, a dose-dependent decrease in the activity of 17-OH was observed with increasing amounts of drug. RU486 decreased 17-OH activity by 12 and 29% below that of basal activity at concentrations equal to and ten times substrate. At 50- and 100-fold excess, RU486 further decreased 17-OH activity by 42 (P <0.01) and 48% (P <0.005). In conclusion, RU486 directly inhibits human ovarian 17-OH activity, but does not affect AR activity or E2 production in vitro. Clinically observed decreases in serum E2 levels may be due to inhibition of enzymatic steps proximal to E2 synthesis. These findings support the authors' previous observations suggesting that RU486 has a direct affect on human ovarian steroidogenesis.

AB - Previous studies in the authors' laboratory suggest that the antiprogestin RU486 may directly affect human ovarian progesterone production. The possibility that this compound could affect other steps in human ovarian steroidogenesis was examined by studying its effects on estrogen production in cultured human granulosa cells and on human ovarian aromatase (AR) and 17-hydroxylase (17-OH) activities in vitro. RU486 had no effect on media estradiol (E2) levels as measured by radioimmunoassay (RIA) over a 24-hour incubation period. Furthermore, no effect on ovarian AR activity occurred at concentrations of RU486 100 times substrate. However, a dose-dependent decrease in the activity of 17-OH was observed with increasing amounts of drug. RU486 decreased 17-OH activity by 12 and 29% below that of basal activity at concentrations equal to and ten times substrate. At 50- and 100-fold excess, RU486 further decreased 17-OH activity by 42 (P <0.01) and 48% (P <0.005). In conclusion, RU486 directly inhibits human ovarian 17-OH activity, but does not affect AR activity or E2 production in vitro. Clinically observed decreases in serum E2 levels may be due to inhibition of enzymatic steps proximal to E2 synthesis. These findings support the authors' previous observations suggesting that RU486 has a direct affect on human ovarian steroidogenesis.

UR - http://www.scopus.com/inward/record.url?scp=0023203131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023203131&partnerID=8YFLogxK

M3 - Article

C2 - 3497059

AN - SCOPUS:0023203131

VL - 48

SP - 229

EP - 233

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 2

ER -